Category

Research

May24 MediSieve Receives Approval for First-in-Man Clinical Investigation
May 24, 2022

MediSieve Receives Approval for First-in-Man Clinical Investigation
Radboud University Medical Center will perform the first trial of the Novel Magnetic Haemoflitratio...

More

Research

Feb02 First Clinical Trials to Start at Radboud Medical Centre
February 02, 2022

First Clinical Trials to Start at Radboud Medical Centre
Award winning company MediSieve is set to start their first-in-man clinical trials in the first qua...

More

MediSieve, Research

Feb15 MediSieve Expands Their Lab Space
February 15, 2021

MediSieve Expands Their Lab Space
The beginning of the year has been full of exciting changes. To comply with government guidelines f...

More

Research

Apr29 MediSieve expands its research into treating COVID-19
April 29, 2020

MediSieve expands its research into treating COVID-19
Recent studies show that patients with the most serious forms of the coronavirus had high levels of...

More

Research

Apr03 COVID-19 Response
April 03, 2020

COVID-19 Response
Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine...

More

MediSieve, Research

Mar02 MediSieve Receives The Second Patent In The US For The Magnetic Mixing Device
March 02, 2020

MediSieve Receives The Second Patent In The US For The Magnetic Mixing Device
MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, has fin...

More

Research

May08 MediSieve to take blood filtration research into fight against leukaemia
May 08, 2018

MediSieve to take blood filtration research into fight against leukaemia
MediSieve, the company behind a revolutionary magnetic sieve that filters out malaria-infected cell...

More

Copyright 2022 by MediSieve. Company number 8983823 registered in England and Wales. Registered address: 48 Chancery Lane, London, WC2A 1JF.
Terms of use | Privacy Policy |